Do endothelial progenitor cells modify our strategy to treat risk factors?
Hlavní autoři: | Tousoulis, D, Andreou, I, Antoniades, C, Siasos, G, Stougiannos, P, Trikas, A, Stefanadis, C |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2011
|
Podobné jednotky
-
Do endothelial progenitor cells modify our strategy to treat risk factors?
Autor: Tousoulis, D, a další
Vydáno: (2010) -
Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives.
Autor: Andreou, I, a další
Vydáno: (2006) -
Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases.
Autor: Tousoulis, D, a další
Vydáno: (2008) -
Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes.
Autor: Bakogiannis, C, a další
Vydáno: (2012) -
The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development.
Autor: Briasoulis, A, a další
Vydáno: (2011)